Watch All Shows Victor Davis Hanson Tony Kinnett Daily Signal Signal Sitdown

Watch All Shows Victor Davis Hanson Tony Kinnett Daily Signal Signal Sitdown

Home – Congressional & Capitol Hill News – FDA Confirmation Hearing Gives Update on Abortion Pill Study Under New Leadership

FDA Confirmation Hearing Gives Update on Abortion Pill Study Under New Leadership

Virginia Grace McKinnon

Dr. Heidi Overton, nominated by President Donald Trump to lead the Food and Drug Administration, appeared before a Senate committee on Thursday and shared an update on the long-awaited abortion pill study.

Overton told the Senate Committee on Health, Education, Labor and Pensions that if she is confirmed, the updates to the study would be on her desk immediately. She assured the committee of her commitment to oversee the study and provide transparency of the results.

The FDA is currently conducting a safety study on the chemical abortion drug mifepristone. The Biden administration formerly changed the risk evaluation and mitigation strategy, or REMS, and removed the in-person prescription requirement, allowing for unregulated use of the abortion pill.

Now pro-life lawmakers are attempting to remove the drug from the market entirely. This starts with the FDA conducting the safety study, which is expected to be completed by the end of the year.

“I’m disappointed that the FDA has removed so many guardrails from this dangerous drug, which carries the........

© The Daily Signal